Form 4: Jazz Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mary Elizabeth Henderson, SVP of Technical Operations at Jazz Pharmaceuticals, sold 698 ordinary shares to satisfy tax obligations from vesting restricted stock units.
Summary
- Mary Elizabeth Henderson, a Senior Vice President at Jazz Pharmaceuticals, sold 698 ordinary shares of the company on March 7, 2025.
- The shares were sold at a price of $138.23 per share.
- The sale was executed to cover tax obligations arising from the vesting of previously granted restricted stock units.
- Following the transaction, Henderson directly owns 23,077 ordinary shares of Jazz Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's stock sale for tax purposes. It doesn't convey any particularly positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence and are often related to tax obligations or portfolio diversification. The sale itself is unlikely to have a significant impact on the company's overall performance or stock price.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Date of the share sale transaction. |
| 03/11/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.